Old/New: HALT-IT and TXA in GI Bleed with cirrhosis
ICU Ed and Todd-Cast
Trial of Trans-examic Acid in Upper GI Bleeding with Cirrhosis
This chapter focuses on a new trial involving trans-examic acid (TXA) in patients with advanced cirrhosis and hyperfibronolysis, aimed at stabilizing clots in upper gastrointestinal bleeding. Discussions include enrollment criteria for patients with cirrhosis, management strategies like endoscopic therapy, outcomes related to treatment failure and re-bleeding, safety events, and conflicting trial results impacting the administration of TXA in clinical practice.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
